Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support
NIDA aims to create a Center to train and support researchers in developing new treatments for substance use disorders, offering education, networking, and resources for early-stage product development.
Funder: National Institutes of Health
Due Dates (Anticipated): March 2026 (application deadline) | September 2026 (full application deadline)
Funding Amounts: Estimated total funding: $3,000,000 | Expected number of awards: 1 | Award duration/details not specified
Summary: Supports establishment of a center to train and support researchers in developing new pharmacotherapies for substance use disorders.
Key Information: This is a forecasted opportunity; dates and details may change.
Description
This opportunity, offered by the National Institute on Drug Abuse (NIDA) at NIH, aims to establish a Center focused on advancing the development of new pharmacotherapies for substance use disorders (SUD). The Center's goals include providing formal training in product development for SUD researchers, supporting early-stage translational research, and advancing promising concepts through technical and financial assistance. Applicants are encouraged to propose a curriculum for product development, outline outreach and networking strategies to engage the research community, and describe infrastructure to support initial experiments. This grant is a cooperative agreement and does not allow clinical trials.
